The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer
Open accessAbstract
Aberrant methylation of several known or putative tumor suppressor genes occurs frequently during the pathogenesis of lung cancers. There are major smoke exposure, histology, geography and gender‐related changes in non‐small cell lung cancer (NSCLC). We investigated smoking‐related, histologic, geographic and gender differences in the methylation profiles of resected NSCLCs. We examined 514 cases of NSCLC and 84 corresponding nonmalignant lung tissues from 4 countries (USA, Australia, Japan and Taiwan) for the methylation status of 7 genes known to be frequently methylated in lung cancers [p16, RASSF1A (RAS association domain family 1), APC, RARβ, CDH13, MGMT and GSTP1]. Multivariate analyses were used for data analysis. Adenocarcinoma was the major histologic type in women and never smokers; analyses that involved smoke exposure and gender were limited to this histology. Our major findings are a) methylation status of any single gene was largely independent of methylation status of other genes; b) the rates of methylation of p16 and APC and the mean Methylation Index (MI), a reflection of the overall methylation status, were significantly higher in ever smokers than in never smokers; c) the mean MI of tumors arising in former smokers was significantly lower than the mean of current smokers; d) the methylation rates of APC, CDH13 and RARβ were significantly higher in adenocarcinomas than in squamous cell carcinomas; e) methylation rates of MGMT and GSTP1 were significantly higher in the USA and Australian cases than in those from Japan and Taiwan; and (f) no significant gender‐related differences in methylation patterns were noted. Our findings demonstrate important smoke exposure, histologic type and geography‐related differences in the methylation profiles of NSCLC tumors. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Cancer burden in the year 2000. The global picture
Parkin, D. M., Bray, F. I., & Devesa, S. S. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00267-2 · Cited by 2,169
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., & Brambilla, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,523
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
Self-citationDifferences in Lung Cancer Risk Between Men and Women: Examination of the Evidence
Zang, E. A., & Wynder, E. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.183 · Cited by 722
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer‐Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., & Minna, J. D. (2001) · PubMed · Cited by 608
Self-citationMolecular Damage in the Bronchial Epithelium of Current and Former Smokers
Wistuba, I. I., Virmani, A. K., Gazdar, A. F., Lam, S., LeRiche, J., Behrens, C., Fong, K. M., Samet, J. M., Srivastava, S., & Minna, J. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.18.1366 · Cited by 485
Self-citationWistuba, I. I., Behrens, C., Virmani, A. K., Mele, G. M., Milchgrub, S., Girard, L., Fondon, J. W., Garner, H. R., McKay, B., Latif, F., et al. (2000) · PubMed · Cited by 405
Self-citationInactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.
Esteller, M., Corn, P. G., Ureña, J. M., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 356
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
Self-citationWistuba, I. I., Behrens, C., Milchgrub, S., Bryant, D., Hung, J., Minna, J. D., & Gazdar, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202349 · Cited by 329
Self-citationKim, D. H., Nelson, H. H., Wiencke, J. K., Zheng, S., Christiani, D. C., Wain, J. C., Mark, E. J., & Kelsey, K. T. (2001) · PubMed · Cited by 325
Herrmann, B. G., & Frischauf, A.-M. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)52018-3 · Cited by 299
Sex differences in lung CYP1A1 expression and DNA adduct levels among lung cancer patients.
Mollerup, S., Ryberg, D., Hewer, A. J., Phillips, D. H., & Haugen, A. (1999) · PubMed · Cited by 272
Cheng, Y., Chiou, H. L., Sheu, G., et al. (2001) · PubMed · Cited by 249
Shriver, S. P., Bourdeau, H. A., Gubish, C. T., Tirpak, D. L., Davis, A. L. G., Luketich, J. D., & Siegfried, J. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.1.24 · Cited by 192
Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
Tsuchiya, T., Tamura, G., Sato, K., Endoh, Y., Sakata, K., Jin, Z., Motoyama, T., Usuba, O., Kimura, W., Nishizuka, S., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203704 · Cited by 176
Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
Sánchez‐Céspedes, M., Ahrendt, S. A., Piantadosi, S., Rosell, R., Monzó, M., Wu, L., Westra, W. H., Yang, S. C., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 169
Issa, J. J., Baylin, S. B., & Belinsky, S. A. (1996) · PubMed · Cited by 164
Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90161-2 · Cited by 158
Changing patterns of lung cancer incidence by histological type.
Devesa, S. S., Shaw, G., & Blot, W. J. (1993) · PubMed · Cited by 155
Promoter-Region Hypermethylation and Gene Silencing in Human Cancer
Herman, J. G., & Baylin, S. B. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_3 · Cited by 151
Kreuzer, M., Boffetta, P., Whitley, E., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0904 · Cited by 148
Lung cancer in nonsmoking women: a multicenter case-control study.
Fontham, E. T. H., Corréa, P., Wu‐Williams, A. H., et al. (1993) · PubMed · Cited by 112
t, S. C., Sinnett, D., & Momparler, R. L. (1998) · Anti-Cancer Drugs · doi:10.1097/00001813-199810000-00001 · Cited by 101
HD-PTP: A Novel Protein Tyrosine Phosphatase Gene on Human Chromosome 3p21.3
Toyooka, S.-I., Ouchida, M., Jitsumori, Y., Tsukuda, K., Sakai, A., Nakamura, A., Shimizu, N., & Shimizu, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3870 · Cited by 59
Self-citationJanssen-Heijnen, M. L. G., Coebergh, J. W. W., Klinkhamer, P. J. J. M., Schipper, R. M., Splinter, T. A. W., & Mooi, A. W. J. (2001) · Epidemiology · doi:10.1097/00001648-200103000-00020 · Cited by 57
Cited by
Christensen, B. C., Houseman, E. A., Marsit, C. J., Zheng, S., Wrensch, M. R., Wiemels, J. L., Nelson, H. H., Karagas, M. R., Padbury, J. F., Bueno, R., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000602 · Cited by 1,075
Lung cancer in never smokers – A review
Couraud, S., Zalcman, G., Milleron, B., Morin, F., & Souquet, P.-J. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.03.007 · Cited by 960
Lung Cancer in Never Smokers: A Review
Subramanian, J., & Govindan, R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8015 · Cited by 655
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression
Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., Siegmund, K. D., Koss, M. N., Hagen, J. A., Lam, W. L., et al. (2012) · Genome Research · doi:10.1101/gr.132662.111 · Cited by 521
Self-citationTokumo, M., Toyooka, S., Kiura, K., Shigematsu, H., Tomii, K., Aoe, M., Ichimura, K., Tsuda, T., Yano, M., Tsukuda, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1167.11.3 · Cited by 490
Self-citation
Metadata
- Authors
- Toyooka, S., Maruyama, R., Toyooka, K. O., McLerran, D., Feng, Z., Fukuyama, Y., Virmani, A. K., Zochbauer‐Muller, S., Tsukuda, K., Sugio, K., Shimizu, N., Shimizu, K., Lee, H., Chen, C., Fong, K. M., Gilcrease, M., Roth, J. A., Minna, J. D., & Gazdar, A. F.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-11-26
- Volume
- 103
- Issue
- 2
- Pages
- 153-160
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2050619503
- Cited by
- 288
- References
- 35
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.